Federal Supply Schedule 36F79721D0205
Award Date
7/15/21
Last Date to Order
7/14/26
Federal Agency
Veterans Integrated Service Network 12
Awardee
G1 Therapeutics, Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Fixed Price with Economic Price Adjustment
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 awarded a Federal Supply Schedule (FSS) contract to Genericus, Inc. under the Pharmaceuticals and Drugs (FSS-61-IB) FSS master schedule. The contract, valued at up to $225,000.00, enables the procurement of drugs, pharmaceuticals, and hematology-related products. As an FSS contract, this is a multiple award vehicle that allows for indefinite delivery of the specified products and services...
This Federal Supply Schedule contract was awarded to ITF Therapeutics LLC, a foreign-owned, self-certified small disadvantaged business, by the Department of Veterans Affairs' Veterans Integrated Service Network 12. The contract has a ceiling value of $225,000.00 and a period of performance through May 14, 2030. The contract is for the procurement of drugs, pharmaceuticals, and hematology-related products under the FSS 65 I B schedule. While the specific products and services were not detailed...
The Federal Supply Schedule (FSS) contract awarded to TG Therapeutics Inc. by the Department of Veterans Affairs (VA), Veterans Integrated Service Network 12, covers the procurement of pharmaceuticals, hematology-related products, and other drugs under GSA Schedule 65 IB. The $250,000 multiple award IDV has a period of performance through May 2028, enabling TG Therapeutics to fulfill orders for these medical commodities to treat veterans across VISN 12 facilities. This is the third FSS...
This Federal Supply Schedule (FSS) contract award to Shield Therapeutics Inc. by the Department of Veterans Affairs (VA) is for the provision of pharmaceutical and drug products under the Pharmaceuticals and Drugs (FSS-61-IB) master GSA schedule. The $225,000 ceiling value contract has a base period of performance through March 14, 2027. As a multiple award schedule, this contract allows the VA and other eligible federal agencies to procure the contracted pharmaceuticals and related hematology...
This Federal Supply Schedule (FSS) contract, awarded by the Department of Veterans Affairs (VA) to Exela Pharma Sciences LLC, is for the procurement of pharmaceuticals, drugs, and hematology-related products under FSS-61-IB. The contract has a ceiling value of $3,030,000.00 and a period of performance through September 28, 2024. As a multiple-award schedule contract, this FSS allows the VA and other eligible federal agencies to issue task orders for a wide range of pharmaceutical and drug...
This Federal Supply Schedule (FSS) contract was awarded by the Department of Veterans Affairs' Veterans Integrated Service Network 12 to Antares Pharma Inc., a for-profit manufacturer of pharmaceutical products. The contract, categorized under the Pharmaceuticals and Drugs (FSS-61-IB) schedule, has a ceiling value of $8,334,100.00 and a period of performance through March 14, 2026. The purpose of this contract is to provide the Department of Veterans Affairs with a range of pharmaceutical and...
This Federal Supply Schedule (FSS) contract was awarded by the Veterans Integrated Service Network 12 (VISN 12) of the U.S. Department of Veterans Affairs (VA) to Verity Pharmaceuticals, Inc., a self-certified small disadvantaged business and manufacturer of goods. The contract is for the provision of Drugs, Pharmaceuticals, & Hematology Related Products under the FSS-61-IB schedule, with a contract ceiling value of $225,000.00 and a period of performance through November 30, 2026. The...
This Federal Supply Schedule contract, awarded by the Veterans Integrated Service Network 12, is for the procurement of drugs, pharmaceuticals, and hematology-related products. The contract was awarded to STI Pharma LLC, a for-profit limited liability company and manufacturer of goods, on August 15, 2017, with a ceiling value of $225,000.00 and a period of performance through May 14, 2026. The contract is part of the Pharmaceuticals and Drugs (FSS-61-IB) Federal Supply Schedule, a multiple-award...
This Federal Supply Schedule (FSS) contract awarded by the Department of Veterans Affairs (VA) to ADC Therapeutics America, Inc. procures a range of pharmaceutical and hematology-related products. The $540,000.00 contract, which runs from October 1, 2021 through September 30, 2026, is part of the Pharmaceuticals and Drugs (FSS-61-IB) GSA Schedule and does not utilize any set-asides. As a multiple award contract, the VA can place task orders against this vehicle to acquire the specified drug...
The Federal Supply Schedule (FSS) contract awarded to Fera Pharmaceuticals, LLC is for the procurement of pharmaceutical drugs, pharmaceuticals, and hematology-related products. The prime contractor, Fera Pharmaceuticals, is a woman-owned small business that supplies the Department of Veterans Affairs (VA) and other government agencies with these products. The FSS contract, valued at up to $450,000.00, was awarded by the VA's Veterans Health Administration Veterans Integrated Service Network...